Evidence map›Paper›PMID 21499258›Full record

ArticleNature cell biology2011

ARFGAP1 promotes AP-2-dependent endocytosis.

Ming Bai, Helge Gad, Gabriele Turacchio, Emanuele Cocucci, Jia-Shu Yang, Jian Li, Galina V Beznoussenko, Zhongzhen Nie, Ruibai Luo, Lianwu Fu and 4 more

Open access · greenAbstract read
In one paragraph

Article in Nature cell biology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
1.9field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 44 citations in OpenAlex.

  1. The ATG14: multi-layer autophagy control and an emerging therapeutic target in cancer.Apoptosis : an international journal on programmed cell death · 2026
    Review
  2. Article
  3. Article
  4. Identification of TPRA1 as a Novel Receptor and Predictive Biomarker for Oncolytic Virus M1.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Article
  5. Article
  6. Article
  7. Trafficking-defective mutant PROKR2 cycles between endoplasmic reticulum and Golgi to attenuate endoplasmic reticulum stress.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 7 institutions in 3 countries.

Ming BaiDivision of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, and Department of Medicine, Harvard Medical School, Boston, Massachusetts 02115, USA.
Helge Gad
Gabriele Turacchio
Emanuele Cocucci
Jia-Shu Yang
Jian Li
Galina V Beznoussenko
Zhongzhen Nie
Ruibai Luo
Lianwu Fu
James F Collawn
Tomas Kirchhausen
Alberto Luini
Victor W Hsu
Brigham and Women's Hospital · USHarvard University · USMario Negri Sud Foundation · ITUniversity of Alabama at Birmingham · USFlorida College · USNational Cancer Institute · USTelethon Institute Of Genetics And Medicine · IT

Funding

Treatments for Nipah Virus InfectionU54AI057159 · NIAID · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI KASPER, DENNIS L. · 2003 to 2013
$113.7M
Mechanisms and Physiology of COPI TransportR37GM058615 · NIGMS · BRIGHAM AND WOMEN'S HOSPITAL · PI HSU, VICTOR W · 2016 to 2025
$6.0M
COPI TransportR01GM058615 · NIGMS · BRIGHAM AND WOMEN'S HOSPITAL · PI HSU, VICTOR W · 2001 to 2015
$5.7M
Dynamics of Clathrin Coat Formation in CellsR01GM075252 · NIGMS · IMMUNE DISEASE INSTITUTE, INC. · PI KIRCHHAUSEN, TOMAS · 2005 to 2018
$4.6M
Cell Biology of CFTR in Polarized EpitheliaR01DK060065 · NIDDK · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI COLLAWN, JAMES F. · 2003 to 2013
$3.1M
Cargo sorting during endocytic recyclingR01GM073016 · NIGMS · BRIGHAM AND WOMEN'S HOSPITAL · PI HSU, VICTOR W · 2005 to 2013
$3.0M
NIAID NIH HHS U54 AI057159NIDDK NIH HHS DK060065NIDDK NIH HHS R01 DK060065NIGMS NIH HHS GM058615NIGMS NIH HHS GM073016NIGMS NIH HHS GM075252NIGMS NIH HHS R01 GM058615NIGMS NIH HHS R01 GM073016NIGMS NIH HHS R01 GM075252NIGMS NIH HHS R37 GM058615Telethon TGM11CB5
6 · The paper itself

Abstract

COPI (coat protein I) and the clathrin-AP-2 (adaptor protein 2) complex are well-characterized coat proteins, but a component that is common to these two coats has not been identified. The GTPase-activating protein (GAP) for ADP-ribosylation factor 1 (ARF1), ARFGAP1, is a known component of the COPI complex. Here, we show that distinct regions of ARFGAP1 interact with AP-2 and coatomer (components of the COPI complex). Selectively disrupting the interaction of ARFGAP1 with either of these two coat proteins leads to selective inhibition in the corresponding transport pathway. The role of ARFGAP1 in AP-2-regulated endocytosis has mechanistic parallels with its roles in COPI transport, as both its GAP activity and coat function contribute to promoting AP-2 transport.

Indexed as

EndocytosisGTPase-Activating ProteinsHumansMicroscopy, ElectronProtein TransportReceptors, TransferrinTranscription Factor AP-2ARFGAP1 protein, humanGTPase-Activating ProteinsReceptors, TransferrinTranscription Factor AP-2

Identifiers

PMID21499258
PMCPMC3087831
OpenAlexW2006157977

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.